PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Clinical and Molecular Hepatology10.3350/cmh.2023.00802023292332-334What should be done to reduce the discrepancy between guidelines and real-life practice for hepatocellular carcinoma in Korea?Min Kyung Park, Yoon Jun Kimhttp://e-cmh.org/upload/pdf/cmh-2023-0080.pdf, http://e-cmh.org/journal/view.php?doi=10.3350/cmh.2023.0080, http://e-cmh.org/upload/pdf/cmh-2023-0080.pdf
Liver Transplantation10.1002/lt.20605200511S2S45-S46Tumor surveillance-what can and should be done? Screening for recurrence of hepatocellular carcinoma after liver transplantationJohn P. Robertshttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Flt.20605, https://onlinelibrary.wiley.com/doi/full/10.1002/lt.20605
Clinical and Molecular Hepatology10.3350/cmh.2023.01012023292352-354Challenges in translating clinical guidelines into real-life practice for management of hepatocellular carcinoma in TaiwanSan-Chi Chenhttp://e-cmh.org/upload/pdf/cmh-2023-0101.pdf, http://e-cmh.org/journal/view.php?doi=10.3350/cmh.2023.0101, http://e-cmh.org/upload/pdf/cmh-2023-0101.pdf
Clinical and Molecular Hepatology10.3350/cmh.2023.01022023292242-251Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspectiveHironori Koga, Hideki Iwamoto, Hiroyuki Suzuki, Shigeo Shimose, Masahito Nakano, Takumi Kawaguchihttp://e-cmh.org/upload/pdf/cmh-2023-0102.pdf, http://e-cmh.org/journal/view.php?doi=10.3350/cmh.2023.0102, http://e-cmh.org/upload/pdf/cmh-2023-0102.pdf
EAU Update Series10.1016/j.euus.2004.01.0042004212-5Diagnosis and Assessment of BPH: What Should Be Done? A Glance at International Clinical Practice GuidelinesJacques Irani, Christian T Brownhttps://api.elsevier.com/content/article/PII:S1570912404000029?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1570912404000029?httpAccept=text/plain
Best Practice & Research Clinical Haematology10.1016/j.beha.2023.1014732023362101473What should be done and what should be avoided when comparing two treatments?Florie Brion Bouvier, Raphaƫl Porcherhttps://api.elsevier.com/content/article/PII:S1521692623000348?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1521692623000348?httpAccept=text/plain
Clinical and Molecular Hepatology10.3350/cmh.2023.00822023292349-351Clinical practice guidelines and real-world practice for hepatocellular carcinoma in Taiwan: Bridging the gapShen-Yung Wanghttp://e-cmh.org/upload/pdf/cmh-2023-0082.pdf, http://e-cmh.org/journal/view.php?doi=10.3350/cmh.2023.0082, http://e-cmh.org/upload/pdf/cmh-2023-0082.pdf
Liver Cancer10.1159/00036773020154285-95Clinical Practice Guidelines for Hepatocellular Carcinoma Differ between Japan, United States, and Europehttps://www.karger.com/Article/Pdf/367730, https://www.karger.com/Article/Pdf/367730
Journal of Liver Cancer10.17998/jlc.2022.11.0720232311-1202022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma http://e-jlc.org/upload/pdf/jlc-2022-11-07.pdf, http://e-jlc.org/journal/view.php?doi=10.17998/jlc.2022.11.07, http://e-jlc.org/upload/pdf/jlc-2022-11-07.pdf
The Korean Journal of Hepatology10.3350/kjhep.2009.15.3.3912009153391Practice guidelines for management of hepatocellular carcinoma 2009 http://synapse.koreamed.org/pdf/10.3350/kjhep.2009.15.3.391, http://synapse.koreamed.org/DOIx.php?id=10.3350/kjhep.2009.15.3.391, http://www.e-cmh.org/upload/pdf/Korean J Hepatol_15_3_391_448.pdf